This page shows the latest tirzepatide news and features for those working in and with pharma, biotech and healthcare.
Lilly is the only FDA-approved company to legally sell products containing tirzepatide. ... contain tirzepatide, and doing so for a use for which Mounjaro is not approved, namely weight loss.".
Eli Lilly’s Mounjaro (tirzepatide) has been recommended by the National Institute for Health and Care Excellence (NICE) as a treatment for poorly controlled type 2 diabetes in adults, alongside diet
The announcement comes after two of Lilly’s diabetes drugs – Mounjaro (tirzepatide) and Trulicity (dulaglutide) – were in short supply in December 2022, which resulted in the US Food and Drug Administration
In addition to the tremendous ongoing launch of Mounjaro in type 2 diabetes and expected future opportunities to treat obesity and obesity-related metabolic outcomes with tirzepatide, we plan to invest ... regulatory submission for tirzepatide in
The company plans to initiate a rolling submission of a new drug application for tirzepatide this year. ... Crucially, the overall safety and tolerability profile of tirzepatide was similar to other incretin-based therapies approved for the treatment of
The company has delivered 17 new medicines over the course of the last eight years, including tirzepatide, which received US Food and Drug Administration (FDA) approval as Mounjaro, for the treatment
More from news
Approximately 5 fully matching, plus 6 partially matching documents found.
No results were found
We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...